Options for Evaluating Treatment Benefit in MCI and Prodromal Alzheimer’s Disease: Content Validity of the Perceived Deficits Questionnaire (PDQ) in Patients with Early Symptoms of Cognitive Decline

ISSN Print: 2169-2459
ISSN Online: 2169-2467
www.scirp.org/journal/aad
E-mail: aad@scirp.org

Citations

"Options for Evaluating Treatment Benefit in MCI and Prodromal Alzheimer’s Disease: Content Validity of the Perceived Deficits Questionnaire (PDQ) in Patients with Early Symptoms of Cognitive Decline"
written by William R. Lenderking, Anna Steenrod, Katja Rüdell, Stephanie Klapper, Kellee Howard, Maren Gaudig,
published by Advances in Alzheimer's Disease, Vol.3 No.1, 2014

has been cited by the following article(s):

[1]	Targeting cognitive function: Development of a cognitive training intervention for diabetes
	2020

[2]	Symptom clusters of subjective cognitive decline amongst cognitively normal older persons and their utilities in predicting objective cognitive performance: structural …
	2019

[3]	Identifying patterns in signs and symptoms preceding the clinical diagnosis of Alzheimer's disease
	2018

[4]	Thinking About Cognitive Function: Perceptions of Cognitive Changes in People With Type 2 Diabetes
	The Diabetes Educator, 2017

[1]	Exploring shared therapeutic targets for Alzheimer’s disease and glioblastoma using network pharmacology and protein-protein interaction approach Frontiers in Chemistry, 2025 DOI:10.3389/fchem.2025.1549186

[2]	Symptom clusters of subjective cognitive decline amongst cognitively normal older persons and their utilities in predicting objective cognitive performance: structural equation modelling European Journal of Neurology, 2019 DOI:10.1111/ene.13958

[3]	Thinking About Cognitive Function: Perceptions of Cognitive Changes in People With Type 2 Diabetes The Diabetes Educator, 2017 DOI:10.1177/0145721717729806

Top